Louise Bannon Celebrates Barbara Adams Krolak’s 10-Year Anniversary at ISTH
Louise Bannon, Global Communications Leader, Director of Membership, Marketing and External Relations of ISTH, shared on LinkedIn:
”Today marks 10 years that Barbara Adams Krolak has been part of the ISTH team, and I couldn’t let this milestone pass without recognizing her incredible talent, leadership and heart!
Barbara has been a trusted partner from day one.
She brings sharp strategic thinking, marketing savvy and a calm, thoughtful approach that makes every challenge feel manageable.
Her counsel, creativity and ability to see the big picture have strengthened our work in countless ways.
What I admire most is her dedication.
She always goes the extra mile, leads with integrity and lifts others up along the way.
Our team and community are stronger because of her!
Thank you, Barbara, for your decade of impact, wisdom and partnership.
It’s a privilege to work alongside you and learn from you every day.
Here’s to celebrating all you’ve accomplished and the continued success ahead!”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’